Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches

Published:2014-09-24 Issue:1 Volume:12 Page:
ISSN:1477-5956
Container-title:Proteome Science
language:en
Short-container-title:Proteome Sci

Author:

Popescu Ionela Daniela,Codrici Elena,Albulescu Lucian,Mihai Simona,Enciu Ana-Maria,Albulescu Radu,Tanase Cristiana Pistol

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Biochemistry

Link

http://link.springer.com/content/pdf/10.1186/s12953-014-0047-0.pdf

Reference67 articles.

1. Kocevar N, Hudler P, Komel R: The progress of proteomic approaches in searching for cancer biomarkers. N Biotechnol 2013, 30: 319–326. 10.1016/j.nbt.2012.11.011

2. Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN: Molecularly targeted therapy for malignant glioma. Cancer 2007, 110: 13–24. 10.1002/cncr.22741

3. Wei P, Zhang W, Yang LS, Zhang HS, Xu XE, Jiang YH, Huang FP, Shi Q: Serum GFAP autoantibody as an ELISA-detectable glioma marker. Tumour Biol 2013, 34: 2283–2292. 10.1007/s13277-013-0770-7

4. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 2010, 60: 166–193. 10.3322/caac.20069

5. Brat DJ, Castellano-Sanchez A, Kaur B, Van Meir EG: Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation. Adv Anat Pathol 2002, 9: 24–36. 10.1097/00125480-200201000-00004

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum CD133-Associated Proteins Identified by Machine Learning Are Connected to Neural Development, Cancer Pathways, and 12-Month Survival in Glioblastoma;Cancers;2024-08-01

2. Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?;Molecular Oncology;2024-05-27

3. Liquid Biopsy in the Future of Glioma Diagnosis and Treatment Occupies a Key Position;Experts' Perspectives on Medical Advances;2024

4. The duality of CXCR3 in glioblastoma: unveiling autocrine and paracrine mechanisms for novel therapeutic approaches;Cell Death & Disease;2023-12-16

5. Comparative Analysis of Amino Acid Profiles in Patients with Glioblastoma and Meningioma Using Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS);Molecules;2023-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3